| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.22 | 0.007 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |